Monroe Terilyn J. — SEC Form 4 filings
SEC reporting owner CIK 1652956. 16 Form 4 filings on record with FilingPulse; latest filed 2026-08-13.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-02-27 to 2026-08-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 5 filings — 123,901 shares, $15,948,713 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 42.
- Largest priced transaction: sale of 19,014 shares @ $165.16 ($3,140,310) in Guardant Health, Inc., filed 2026-08-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Guardant Health, Inc. (GH) | Chief People Officer | 16 | — | 19 legs · 123,901 sh · $15,948,713 | 42 |
Form 4 filings — Monroe Terilyn J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-13 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 32,288 @ $20.14 · Option exercise (M): 14,012 @ $28.61 · Sale (S): 3,704 @ $163.41 · Sale (S): 9,934 @ $164.27 · Sale (S): 19,014 @ $165.16 · Sale (S): 13,248 @ $166.11 · +3 more | EDGAR |
| 2026-07-02 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 2,659 @ $0 · Option exercise (M): 1,361 @ $0 · Tax withholding (F): 2,099 @ $170.77 · Option exercise (M): 2,659 (derivative) @ $0 · Option exercise (M): 1,361 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | Guardant Health, Inc. (GH) | Sale (S): 3,832 @ $92.68 | EDGAR |
| 2026-04-02 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 2,660 @ $0 · Option exercise (M): 5,359 @ $0 · Tax withholding (F): 4,187 @ $91.15 · Option exercise (M): 2,660 (derivative) @ $0 · Option exercise (M): 5,359 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | Guardant Health, Inc. (GH) | Grant/award (A): 17,040 (derivative) @ $0 | EDGAR |
| 2026-01-22 | 4 | Guardant Health, Inc. (GH) | Sale (S): 1,703 @ $112.34 · Sale (S): 3,619 @ $113.48 · Sale (S): 3,249 @ $115.70 | EDGAR |
| 2026-01-16 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 17,379 @ $0 · Tax withholding (F): 8,808 @ $111.98 · Option exercise (M): 17,379 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | Guardant Health, Inc. (GH) | Sale (S): 6,311 @ $111.75 · Sale (S): 3,632 @ $112.62 · Sale (S): 88 @ $113.44 | EDGAR |
| 2026-01-05 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 14,896 @ $0 · Option exercise (M): 2,659 @ $0 · Tax withholding (F): 7,524 @ $102.14 · Option exercise (M): 14,896 (derivative) @ $0 · Option exercise (M): 2,659 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 35,000 @ $20.14 · Option exercise (M): 15,000 @ $28.61 · Sale (S): 18,576 @ $105.33 · Sale (S): 23,974 @ $106.15 · Sale (S): 6,786 @ $106.90 · Sale (S): 664 @ $107.85 · +5 more | EDGAR |
| 2025-10-02 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 10,477 @ $0 · Tax withholding (F): 5,310 @ $62.65 · Option exercise (M): 10,477 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Guardant Health, Inc. (GH) | Grant/award (A): 24,363 (derivative) @ $0 · Grant/award (A): 16,242 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 14,894 @ $0 · Tax withholding (F): 6,565 @ $42.55 · Option exercise (M): 14,894 (derivative) @ $0 | EDGAR |
| 2025-01-16 | 4 | Guardant Health, Inc. (GH) | Option exercise (M): 17,378 @ $0 · Tax withholding (F): 6,420 @ $37.50 · Option exercise (M): 17,378 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | Guardant Health, Inc. (GH) | Grant/award (A): 47,627 (derivative) @ $0 · Grant/award (A): 31,751 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | Guardant Health, Inc. (GH) | Grant/award (A): 78,204 (derivative) @ $0 · Grant/award (A): 52,136 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1652956 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →